Literature DB >> 19585106

Short-term antidepressant treatment modulates amygdala response to happy faces.

Ray Norbury1, Matthew J Taylor, Sudhakar Selvaraj, Susannah E Murphy, Catherine J Harmer, Philip J Cowen.   

Abstract

RATIONALE: We have previously demonstrated that antidepressant medication facilitates the processing of positive affective stimuli in healthy volunteers. These early effects of antidepressants may be an important component in the therapeutic effects of antidepressant treatment in patients with depression and anxiety.
OBJECTIVES: Here we used functional magnetic resonance imaging in a double-blind, randomised, placebo-controlled between-groups design to investigate the effects of short-term (7-10 days) treatment with the selective serotonin reuptake inhibitor, citalopram, on the amygdala response to positive and negative facial expressions in healthy volunteers.
RESULTS: Citalopram was associated with increased amygdala activation to happy faces relative to placebo control, without changes in levels of mood or anxiety.
CONCLUSIONS: These early, direct effects of antidepressant administration on emotional processing are consistent with a cognitive neuropsychological model of antidepressant action.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585106     DOI: 10.1007/s00213-009-1597-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Amygdala response to happy faces as a function of extraversion.

Authors:  Turhan Canli; Heidi Sivers; Susan L Whitfield; Ian H Gotlib; John D E Gabrieli
Journal:  Science       Date:  2002-06-21       Impact factor: 47.728

3.  Beyond threat: amygdala reactivity across multiple expressions of facial affect.

Authors:  Daniel A Fitzgerald; Mike Angstadt; Laura M Jelsone; Pradeep J Nathan; K Luan Phan
Journal:  Neuroimage       Date:  2005-12-20       Impact factor: 6.556

Review 4.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

5.  The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.

Authors:  R Norbury; C E Mackay; P J Cowen; G M Goodwin; C J Harmer
Journal:  Mol Psychiatry       Date:  2007-10-23       Impact factor: 15.992

Review 6.  Predictors of amygdala activation during the processing of emotional stimuli: a meta-analysis of 385 PET and fMRI studies.

Authors:  Sergi G Costafreda; Michael J Brammer; Anthony S David; Cynthia H Y Fu
Journal:  Brain Res Rev       Date:  2007-11-12

Review 7.  Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.

Authors:  Matthew J Taylor; Nick Freemantle; John R Geddes; Zubin Bhagwagar
Journal:  Arch Gen Psychiatry       Date:  2006-11

8.  A susceptibility gene for affective disorders and the response of the human amygdala.

Authors:  Ahmad R Hariri; Emily M Drabant; Karen E Munoz; Bhaskar S Kolachana; Venkata S Mattay; Michael F Egan; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2005-02

9.  Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.

Authors:  Catherine J Harmer; Nicholas C Shelley; Philip J Cowen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

10.  Neural responses to happy facial expressions in major depression following antidepressant treatment.

Authors:  Cynthia H Y Fu; Steve C R Williams; Michael J Brammer; John Suckling; Jieun Kim; Anthony J Cleare; Nicholas D Walsh; Martina T Mitterschiffthaler; Chris M Andrew; Emilio Merlo Pich; Edward T Bullmore
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

View more
  42 in total

Review 1.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

2.  Duloxetine effects on striatal resting-state functional connectivity in patients with major depressive disorder.

Authors:  Li Wang; Jing An; Hong-Mei Gao; Ping Zhang; Chao Chen; Ke Li; Philip B Mitchell; Tian-Mei Si
Journal:  Hum Brain Mapp       Date:  2019-05-08       Impact factor: 5.038

3.  Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder.

Authors:  Teresa A Victor; Maura L Furey; Stephen J Fromm; Arne Ohman; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2010-11

4.  Fluctuations in [¹¹C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans.

Authors:  Patrick MacDonald Fisher; Mette Ewers Haahr; Christian Gaden Jensen; Vibe Gedsoe Frokjaer; Hartwig Roman Siebner; Gitte Moos Knudsen
Journal:  Neuropsychopharmacology       Date:  2015-01-06       Impact factor: 7.853

5.  Regulation of emotional response in juvenile monkeys treated with fluoxetine: MAOA interactions.

Authors:  M S Golub; C E Hogrefe; A M Bulleri
Journal:  Eur Neuropsychopharmacol       Date:  2016-11-13       Impact factor: 4.600

Review 6.  Affective cognition and its disruption in mood disorders.

Authors:  Rebecca Elliott; Roland Zahn; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

7.  Real-Time Functional Magnetic Resonance Imaging Amygdala Neurofeedback Changes Positive Information Processing in Major Depressive Disorder.

Authors:  Kymberly D Young; Masaya Misaki; Catherine J Harmer; Teresa Victor; Vadim Zotev; Raquel Phillips; Greg J Siegle; Wayne C Drevets; Jerzy Bodurka
Journal:  Biol Psychiatry       Date:  2017-03-28       Impact factor: 13.382

8.  Neural correlates of social approach and withdrawal in patients with major depression.

Authors:  Birgit Derntl; Eva-Maria Seidel; Simon B Eickhoff; Thilo Kellermann; Ruben C Gur; Frank Schneider; Ute Habel
Journal:  Soc Neurosci       Date:  2011-07-21       Impact factor: 2.083

Review 9.  Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety.

Authors:  Esther Asan; Maria Steinke; Klaus-Peter Lesch
Journal:  Histochem Cell Biol       Date:  2013-03-15       Impact factor: 4.304

Review 10.  A neurocognitive model for understanding treatment action in depression.

Authors:  Matthew B Warren; Abbie Pringle; Catherine J Harmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.